Pluripotent stem cells escape from senescenceassociated DNA methylation changes

Genome Research

Volumn 23, Issue 2, 2013, Pages 248-259

  Koch, Carmen M ^a   Reck, Kristina ^a   Shao, Kaifeng ^b   Lin, Qiong ^a   Joussen, Sylvia ^a   Ziegler, Patrick ^a   Walenda, Gudrun ^a   Drescher, Wolf ^a   Opalka, Bertram ^c   May, Tobias ^d   Brummendorf, Tim ^a   Zenke, Martin ^a,b   Saric, Tomo ^a   Wagner, Wolfgang ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; MITOCHONDRIAL DNA; TELOMERASE;

ARTICLE; CELL AGING; CELL CULTURE; CELL IMMORTALIZATION; CONTROLLED STUDY; DEVELOPMENTAL GENE; DNA METHYLATION; ENZYME ACTIVE SITE; HUMAN; HUMAN CELL; IRRADIATION; MESENCHYMAL STROMA CELL; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TELOMERE;

ADULT; AGED; CELL AGING; CELL LINE, TRANSFORMED; CELLS, CULTURED; DNA METHYLATION; EPIGENESIS, GENETIC; GAMMA RAYS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; MODELS, BIOLOGICAL; PLURIPOTENT STEM CELLS;

EID: 84873394089     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.141945.112     Document Type: Article

References (77)

1. Acevedo LG, Bieda M, Green R, Farnham PJ. 2008. Analysis of the mechanisms mediating tumor-specific changes in gene expression in human liver tumors. Cancer Res 68: 2641-2651.
2. Ball MP, Li JB, Gao Y, Lee JH, LeProust EM, Park IH, Xie B, Daley GQ, Church GM. 2009. Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nat Biotechnol 27: 361-368.
3. Banito A, Rashid ST, Acosta JC, Li S, Pereira CF, Geti I, Pinho S, Silva JC, Azuara V, Walsh M, et al. 2009. Senescence impairs successful reprogramming to pluripotent stem cells. Genes Dev 23: 2134-2139.
4. Bazarov AV, Jae LW, Bazarov I, Bosire M, Hines WC, Stankovich B, Chicas A, Lowe SW, Yaswen P. 2012. The specific role of pRb in p16 (INK4A)-mediated arrest of normal and malignant human breast cells. Cell Cycle 11: 1008-1013.
5. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, Weinberg RA. 2008. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40: 499-507.
6. Benetti R, Garcia-Cao M, Blasco MA. 2007. Telomere length regulates the epigenetic status of mammalian telomeres and subtelomeres. Nat Genet 39: 243-250.
7. Bibikova M, Barnes B, Tsan C, Ho V, Klotzle B, Le JM, Delano D, Zhang L, Schroth GP, Gunderson KL, et al. 2011. High density DNA methylation array with single CpG site resolution. Genomics 98: 288-295.
8. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE. 1998. Extension of life-span by introduction of telomerase into normal human cells. Science 279: 349-352.
9. Bork S, Pfister S, Witt H, Horn P, Korn B, Ho AD, Wagner W. 2010. DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells. Aging Cell 9: 54-63.
10. Cai J, Li W, Su H, Qin D, Yang J, Zhu F, Xu J, He W, Guo X, Labuda K, et al. 2010. Generation of human induced pluripotent stem cells from umbilical cord matrix and amniotic membrane mesenchymal cells. J Biol Chem 285: 11227-11234.
11. Campisi J, d'Adda di FF. 2007. Cellular senescence: When bad things happen to good cells. Nat Rev Mol Cell Biol 8: 729-740.
12. Cawthon RM. 2009. Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res 37: e21. doi: 10/1093/nar/gkn1027.
13. Cholewa D, Stiehl T, Schellenberg A, Bokermann G, Joussen S, Koch C, Walenda T, Pallua N, Marciniak-Czochra A, Suschek CV, et al. 2011. Expansion of adipose mesenchymal stromal cells is affected by human platelet lysate and plating density. Cell Transplant 20: 1409-1422.
14. Chou DM, Adamson B, Dephoure NE, Tan X, Nottke AC, Hurov KE, Gygi SP, Colaiacovo MP, Elledge SJ. 2010. A chromatin localization screen reveals poly (ADP ribose)-regulated recruitment of the repressive polycomb and NuRD complexes to sites of DNA damage. Proc Natl Acad Sci 107: 18475-18480.
15. Cmielova J, Havelek R, Soukup T, Jiroutova A, Visek B, Suchanek J, Vavrova J, Mokry J, Muthna D, Bruckova L, et al. 2012. Gamma radiation induces senescence in human adult mesenchymal stem cells from bone marrow and periodontal ligaments. Int J Radiat Biol 88: 393-404.
16. Collas P. 2010. Programming differentiation potential in mesenchymal stem cells. Epigenetics 5: 476-482.
17. Debacq-Chainiaux F, Erusalimsky JD, Campisi J, Toussaint O. 2009. Protocols to detect senescence-associated b-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc 4: 1798-1806.
18. Delbarre E, Jacobsen BM, Reiner AH, Sorensen AL, Kuntziger T, Collas P. 2010. Chromatin environment of histone variant H3.3 revealed by quantitative imaging and genome-scale chromatin and DNA immunoprecipitation. Mol Biol Cell 21: 1872-1884.
19. Di Leonardo A, Linke SP, Clarkin K, Wahl GM. 1994. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev 8: 2540-2551.
20. Doi A, Park IH,Wen B, Murakami P, AryeeMJ, Irizarry R, Herb B, Ladd-Acosta C, Rho J, Loewer S, et al. 2009. Differential methylation of tissue-and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet 41: 1350-1353.
21. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317.
22. Dunham MA, Neumann AA, Fasching CL, Reddel RR. 2000. Telomere maintenance by recombination in human cells. Nat Genet 26: 447-450.
23. Gonzalo S, Jaco I, Fraga MF, Chen T, Li E, Esteller M, Blasco MA. 2006. DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat Cell Biol 8: 416-424.
24. Harness JV, Turovets NA, Seiler MJ, Nistor G, Altun G, Agapova LS, Ferguson D, Laurent LC, Loring JF, Keirstead HS. 2011. Equivalence of conventionally-derived and parthenote-derived human embryonic stem cells. PLoS ONE 6: e14499. doi: 10.1371/journal.pone.0014499.
25. Hawkins RD, Hon GC, Lee LK, Ngo Q, Lister R, Pelizzola M, Edsall LE, Kuan S, Luu Y, Klugman S, et al. 2010. Distinct epigenomic landscapes of pluripotent and lineage-committed human cells. Cell Stem Cell 6: 479-491.
26. Hayflick L, Moorhead P. 1961. The serial cultivation of human diploid cell strains. Exp Cell Res 25: 585-621.
27. Horn P, Bokermann G, Cholewa D, Bork S,Walenda T, Koch C, DrescherW, Hutschenreuther G, Zenke M, Ho A, et al. 2010. Comparison of individual platelet lysates for isolation of human mesenchymal stromal cells. Cytotherapy 12: 888-898.
28. Igarashi K, Sakimoto I, Kataoka K, Ohta K, Miura M. 2007. Radiationinduced senescence-like phenotype in proliferating and plateau-phase vascular endothelial cells. Exp Cell Res 313: 3326-3336.
29. Kang TW, Yevsa T,Woller N, Hoenicke L,Wuestefeld T, Dauch D, Hohmeyer A, Gereke M, Rudalska R, Potapova A, et al. 2011. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 479: 547-551.
30. Kawamura T, Suzuki J,Wang YV, Menendez S,Morera LB, Raya A,Wahl GM, Belmonte JC. 2009. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 460: 1140-1144.
31. Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA, Klingelhutz AJ. 1998. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396: 84-88.
32. Koch C, Suschek CV, Lin Q, Bork S, GoergensM, Joussen S, Pallua N, Ho AD, Zenke M, Wagner W. 2011. Specific age-associated DNA methylation changes in human dermal fibroblasts. PLoS ONE 6: e16679. doi: 10.1371/journal.pone.0016679.
33. Koch CM, Joussen S, Schellenberg A, Lin Q, Zenke M, Wagner W. 2012. Monitoring of cellular senescence by DNA-methylation at specific CpG sites. Aging Cell 11: 366-369.
34. Kondo Y, Shen L, Cheng AS, Ahmed S, Boumber Y, Charo C, Yamochi T, Urano T, Furukawa K, Kwabi-Addo B, et al. 2008. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat Genet 40: 741-750.
35. Lapasset L, Milhavet O, Prieur A, Besnard E, Babled A, Ait-Hamou N, Leschik J, Pellestor F, Ramirez JM, De VJ, et al. 2011. Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state. Genes Dev 25: 2248-2253.
36. Lee JY, Lee TH. 2012. Effects of DNA methylation on the structure of nucleosomes. J Am Chem Soc 134: 173-175.
37. Lee TI, JennerRG, Boyer LA,GuentherMG, Levine SS,KumarRM,Chevalier B, Johnstone SE, Cole MF, Isono K, et al. 2006. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 125: 301-313.
38. Li H, Collado M, Villasante A, Strati K, Ortega S, Canamero M, Blasco MA, Serrano M. 2009. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 460: 1136-1139.
39. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, Nery JR, Lee L, Ye Z, Ngo QM, et al. 2009. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462: 315-322.
40. Marion RM, Strati K, Li H,MurgaM, Blanco R, Ortega S, Fernandez-Capetillo O, Serrano M, Blasco MA. 2009a. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 460: 1149-1153.
41. Marion RM, Strati K, Li H, Tejera A, Schoeftner S, Ortega S, SerranoM, Blasco MA. 2009b. Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell 4: 141-154.
42. May T, Butueva M, Bantner S, Markusic D, Seppen J, MacLeod RA,Weich H, Hauser H, Wirth D. 2010. Synthetic gene regulation circuits for control of cell expansion. Tissue Eng Part A 16: 441-452.
43. Muller FJ, Schuldt BM, Williams R, Mason D, Altun G, Papapetrou EP, Danner S, Goldmann JE, Herbst A, Schmidt NO, et al. 2011. A bioinformatic assay for pluripotency in human cells. Nat Methods 8: 315-317.
44. Narita M, Nunez S, Heard E, Narita M, Lin AW, Hearn SA, Spector DL, Hannon GJ, Lowe SW. 2003. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113: 703-716.
45. Narita M, Narita M, Krizhanovsky V, Nunez S, Chicas A, Hearn SA, MyersMP, Lowe SW. 2006. A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation. Cell 126: 503-514.
46. Nazor KL, Altun G, Lynch C, Tran H, Harness JV, Slavin I, Garitaonandia I, Muller FJ,Wang YC, Boscolo FS, et al. 2012. Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives. Cell Stem Cell 10: 620-634.
47. Nishino K, Toyoda M, Yamazaki-Inoue M, Fukawatase Y, Chikazawa E, Sakaguchi H, Akutsu H, Umezawa A. 2011. DNA methylation dynamics in human induced pluripotent stem cells over time. PLoS Genet 7: e1002085. doi: 10.1371/journal.pgen.1002085.
48. O'Hagan HM, Mohammad HP, Baylin SB. 2008. Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island. PLoS Genet 4: e1000155. doi: 10.1371/journal. pgen.1000155.
49. O'Hare MJ, Bond J, Clarke C, Takeuchi Y, Atherton AJ, Berry C, Moody J, Silver AR, Davies DC, Alsop AE, et al. 2001. Conditional immortalization of freshly isolated human mammary fibroblasts and endothelial cells. Proc Natl Acad Sci 98: 646-651.
50. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW, Daley GQ. 2008. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451: 141-146.
51. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
52. Rando TA, Chang HY. 2012. Aging, rejuvenation, and epigenetic reprogramming: resetting the aging clock. Cell 148: 46-57.
53. Rinn JL, Kertesz M,Wang JK, Squazzo SL, Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E, et al. 2007. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129: 1311-1323.
54. Sandoval J, Heyn HA, Moran S, Serra-Musach J, Pujana MA, Bibikova M, Esteller M. 2011. Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics 6: 692-702.
55. Sasai N, Defossez PA. 2009. Many paths to one goal The proteins that recognize methylated DNA in eukaryotes. Int J Dev Biol 53: 323-334.
56. Schellenberg A, Lin Q, Schu eler H, Koch C, Joussen S, Denecke B, Walenda G, Pallua N, Suschek C, Zenke M, et al. 2011. Replicative senescence of mesenchymal stem cells causes DNA-methylation changes which correlate with repressive histone marks. Aging (Albany NY) 3: 873-888.
57. Schellenberg A, Stiehl T, Horn P, Joussen S, Pallua N, Ho A,WagnerW. 2012. Population dynamics of mesenchymal stromal cells during culture expansion. Cytotherapy 14: 401-411.
58. Schlesinger Y, Straussman R, Keshet I, Farkash S, Hecht M, Zimmerman J, Eden E, Yakhini Z, Ben-Shushan E, Reubinoff BE, et al. 2007. Polycombmediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet 39: 232-236.
59. Schoeftner S, Blasco MA. 2009. A 'higher order' of telomere regulation: Telomere heterochromatin and telomeric RNAs. EMBO J 28: 2323-2336.
60. Seiler DM, Rouquette J, Schmid VJ, Strickfaden H, Ottmann C, Drexler GA, Mazurek B, Greubel C, Hable V, Dollinger G, et al. 2011. Double-strand break-induced transcriptional silencing is associated with loss of trimethylation at H3K4. Chromosome Res 19: 883-899.
61. Seluanov A, Gorbunova V, Falcovitz A, Sigal A, Milyavsky M, Zurer I, Shohat G, Goldfinger N, Rotter V. 2001. Change of the death pathway in senescent human fibroblasts in response to DNA damage is caused by an inability to stabilize p53. Mol Cell Biol 21: 1552-1564.
62. Shao K, Koch CM, Gupta MK, Lin Q, Lenz M, Laufs S, Denecke B, Schmidt M, Linke M, Hennies HC, et al. 2012. Induced pluripotent mesenchymal stromal cell clones retain donor-derived differences inDNA methylation profiles. Mol Ther (in press).
63. Shay JW, Roninson IB. 2004. Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 23: 2919-2933.
64. Sorensen AL, Jacobsen BM, Reiner AH, Andersen IS, Collas P. 2010. Promoter DNA methylation patterns of differentiated cells are largely programmed at the progenitor stage. Mol Biol Cell 21: 2066-2077.
65. Sperka T, Song Z, Morita Y, Nalapareddy K, Guachalla LM, Lechel A, Begus-Nahrmann Y, Burkhalter MD, Mach M, Schlaudraff F, et al. 2012. Puma and p21 represent cooperating checkpoints limiting selfrenewal and chromosomal instability of somatic stem cells in response to telomere dysfunction. Nat Cell Biol 14: 73-79.
66. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872.
67. Teschendorff AE, Menon U, Gentry-Maharaj A, Ramus SJ,Weisenberger DJ, Shen H, Campan M, Noushmehr H, Bell CG, Maxwell AP, et al. 2010. Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. Genome Res 20: 440-446.
68. Utikal J, Polo JM, Stadtfeld M, Maherali N, Kulalert W, Walsh RM, Khalil A, Rheinwald JG, Hochedlinger K. 2009. Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature 460: 1145-1148.
69. Wagner W. 2010. Senescence is heterogeneous in mesenchymal stromal cells -kaleidoscopes for cellular aging. Cell Cycle 9: 2923-2924.
70. Wagner W, Ho AD. 2007. Mesenchymal stem cell preparations-comparing apples and oranges. Stem Cell Rev 3: 239-248.
71. Wagner W, Horn P, Castoldi M, Diehlmann A, Bork S, Saffrich R, Benes V, Blake J, Pfister S, Eckstein V, et al. 2008. Replicative senescence of mesenchymal stem cells: A continuous and organized process. PLoS ONE 5: e2213. doi: 10.1371/journal.pone.0002213.
72. Wei Y, Chen YH, Li LY, Lang J, Yeh SP, Shi B, Yang CC, Yang JY, Lin CY, Lai CC, et al. 2011. CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells. Nat Cell Biol 13: 87-94.
73. Yap KL, Li S, Munoz-Cabello AM, Raguz S, Zeng L, Mujtaba S, Gil J,Walsh MJ, Zhou MM. 2010. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell 38: 662-674.
74. Zeng X. 2007. Human embryonic stem cells: Mechanisms to escape replicative senescence Stem Cell Rev 3: 270-279.
75. Zhao J, Sun BK, Erwin JA, Song JJ, Lee JT. 2008. Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science 322: 750-756.
76. Zhuang J, Jones A, Lee SH, Ng E, Fiegl H, Zikan M, Cibula D, Sargent A, Salvesen HB, Jacobs IJ, et al. 2012. The dynamics and prognostic potential of DNA methylation changes at stem cell gene loci in women's cancer. PLoS Genet 8: e1002517. doi: 10.1371/journal.pgen.1002517.
77. Ziegler P, Schrezenmeier H, Akkad J, Brassat U, Vankann L, Panse J,Wilop S, Balabanov S, Schwarz K, Martens UM, et al. 2012. Telomere elongation and clinical response to androgen treatment in a patient with aplastic anemia and a heterozygous hTERT gene mutation. Ann Hematol 91: 1115-1120.